• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Debra Patt on What In-person Attendees Can Expect at the Community Oncology Conference

Video

Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.

By bringing together administrators, clinicians, and policy makers within community oncology, in-person attendees at the 2022 Community Oncology Conference can discuss issues facing their respective practices and formulate collaborative solutions, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.


Transcript

What can providers and those involved in community oncology gain by being an in-person attendee at the 2022 Community Oncology Conference?

I think that we've all missed seeing each other for the last 2 years, but we've encountered a whole new slew of challenges. The benefit of going to the Community Oncology Alliance meeting is like no other meeting.

It allows you to meet with like-minded individuals that are in community oncology practice—administrators, clinicians, policy makers—and discuss the problems that you've had and formulate collaborative solutions so you can learn from what everyone else is doing. It's a great forum for that and to discuss with people what resources you've developed and share them.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.